-
Testsealabs Debuts at 2025 MEDICA: Three Core IVD Product Lines Unlock a New Paradigm of Precision Testing
Key Exhibition Information Exhibition Name: 2025 MEDICA (International Medical Fair Düsseldorf) Exhibition Time: November 17-20, 2025 Exhibition Venue: Stockumer Kirchstraße 61, D-40474 Düsseldorf, Germany Testsealabs Booth No.: 3H19 Düsseldorf, Germany, November 17, 2025 —— The 2025 MEDICA...Read more -
Egyptian Clients Visit Testsealabs to Discuss Cooperation
Hangzhou Testsea Biotechnology Co., Ltd. (Testsealabs) recently welcomed a delegation of key clients from Egypt for an extensive visit and productive discussions. The Egyptian delegation conducted a comprehensive tour of Testsealabs’ state-of-the-art production workshops and R&D facilit...Read more -
Revolutionary 3-in-1 Gastrointestinal Test Kits: Fast, Pain-Free Screening for Early Disease Detection
evolutionary 3-in-1 Gastrointestinal Test Kits: Fast, Pain-Free Screening for Early Disease Detection For millions worldwide, digestive discomfort has become a quiet, persistent concern. A late-night stomachache brushed off as “indigestion,” occasional bloating dismissed as a “...Read more -
Join Us! Testsealabs at CMEF 2025 (Guangzhou) Booth 20.1S17 to Explore Diagnostic Technology
Testsealabs, a leading name in the global medical technology industry, is gearing up to make a standout appearance at the 92nd China International Medical Equipment (Autumn) Expo (CMEF)—one of the world’s premier healthcare technology gatherings. Set to run from September 26-29, 2025, the expo wi...Read more -
Hangzhou Testsealabs to Showcase Core Precision Diagnostic Products at Pharmedi Vietnam 2025
Hangzhou Testsealabs, a leading player in the global precision diagnostic industry, is thrilled to announce its participation in Pharmedi Vietnam 2025—Southeast Asia’s premier medical and healthcare exhibition. Backed by Vietnam’s Ministry of Health and recognized by the Vietnam Medical Device A...Read more -
Dominican Republic Delegation Visits Hangzhou Testsea Biotechnology, Exploring Future Collaborations in IVD Diagnostics
HANGZHOU, China – [Date of Visit, August 22, 2025] – Hangzhou Testsea Biotechnology Co., Ltd. (Testsealabs), a leading manufacturer of in vitro diagnostic (IVD) rapid tests, was honored to host a distinguished delegation of clients from the Dominican Republic last week. The visit served to streng...Read more -
Testsealabs and Strategic Partner Join Hands with Nobel Laureate to Write a New Chapter in Cell and Gene Therapy
Recently, Mr. Zhou Bin, General Manager of Testsealabs, was invited to attend the contract renewal ceremony between strategic partner Hailiang Biotechnology Co., Ltd. and Professor Randy Schekman, Nobel Laureate in Physiology or Medicine and member of the US National Academy of Sciences. This ren...Read more -
Testsealabs Set to Shine at Asia Health Medlab Asia 2025
Hangzhou Testsea Biotechnology Co., Ltd., renowned as Testsealabs, is thrilled to announce its participation in the highly anticipated Asia Health Medlab Asia, a premier event in the medical laboratory industry. The exhibition will take place from July 16th to 18th, 2025, in Malaysia, and...Read more -
International Clients Explore Testsealabs: Showcasing Excellence in Biotechnology
In a significant display of international collaboration and business growth, Hangzhou Testsea Biotechnology Co., Ltd., known as Testsealabs, recently hosted clients from Ukraine and Somalia. The visit provided an in – depth look into the company’s operations, highlighting its cutting ...Read more -
Testsealabs Pioneers Women’s Health with Advanced Diagnostic Products
In the ever – evolving landscape of women’s health, Testsealabs stands at the forefront as a dedicated innovator, committed to developing cutting – edge solutions that prioritize women’s well – being. With a deep understanding of the challenges women face in maintai...Read more -
Testsealabs Rises to the Challenge Amid Thailand’s COVID-19 Resurgence
In Thailand, the relaxation of border controls and epidemic prevention measures, coupled with a decline in public immunity, has triggered a concerning resurgence of the COVID-19 pandemic. The Thai Ministry of Public Health is closely monitoring the XEC variant of the coronavirus, which exhibits ...Read more -
Testsealabs and hailiangbio have reached a strategic cooperation to integrate their technical channels and jointly explore new global markets
On May 14, 2025, Hangzhou Testsea Biotechnology Co., Ltd.(hereinafter referred to as ” Testsealabs”) and Zhejiang hailiangbio Co., Ltd. (hereinafter referred to as “hailiangbio”) officially entered into a strategic cooperation agreement. The collaboration aims to accelerat...Read more
